IL17A and multiple sclerosis: The pathogenicity of IL-17 has been implicated in rheumatoid arthritis (Lubberts et al. 2002), multiple sclerosis (Lock et al. 2002), cancer (Hyun et al. 2012) and diabetes (Emamaullee et al. 2009).